Maternal drug use in early pregnancy and infant cardiovascular defect

Author： Kallen B.A.J.   Otterblad Olausson P.  

Publisher： Elsevier

ISSN： 0890-6238

Source： Reproductive Toxicology, Vol.17, Iss.3, 2003-05, pp. : 255-261

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Maternal Alcohol Use during Pregnancy, Birth Weight and Early Behavioral Outcomes

By Chen Jen-Hao  

Alcohol and Alcoholism, Vol. 47, Iss. 6, 2012-11 ,pp. : 649-656

Oxford University Press

Access to resources Recommend Favorite

Potential effect of pharmacogenetics on maternal, fetal and infant antiretroviral drug exposure during pregnancy and breastfeeding

By Olagunju Adeniyi   Owen Andrew   Cressey Tim R  

Pharmacogenomics, Vol. 13, Iss. 13, 2012-10 ,pp. : 1501-1522

Future Medicine

Access to resources Recommend Favorite

Immunosuppression in Pregnancy: Choices for Infant and Maternal Health

By Armenti V.T.  

Drugs, Vol. 62, Iss. 16, 2002-01 ,pp. : 2361-2375

Adis International

Access to resources Recommend Favorite

THE IMPACT OF DEPRESSION ON MATERNAL RESPONSES TO INFANT FACES IN PREGNANCY

By  

Infant Mental Health Journal, Vol. 36, Iss. 6, 2015-11 ,pp. : 588-598

John Wiley & Sons Inc

Access to resources Recommend Favorite

Maternal SSRI use not linked to stillbirth, infant mortality

By  

Reactions Weekly, Vol. 1, Iss. 1434, 2013-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite